Director, Chief Executive Officer · Cue Biopharma, Inc. · Common Stock
Side
SELL
Value
$147K
Shares
5,423
Price
$27.19
Executed
Aug 13, 2026
Disclosed
Aug 14, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Aug 13 executedAug 14, 2026 disclosed
CUE · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
2 prior trades recorded in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Lin Shao-Lee filed this Form 4 reporting a open-market sale of CUE on Aug 13, 2026. It became public on Aug 14, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Executive Officer
Lin Shao-Leecik:0001725092
Issuer
Cue Biopharma, Inc.cik:0001645460
Revision history · 0
No field has changed since this record was first ingested.
